{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:37:44Z","timestamp":1790714264873,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","award":["R-719-000-018-281"],"award-info":[{"award-number":["R-719-000-018-281"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001446","name":"Economic Development Board - Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018010","name":"National Additive Manufacturing Innovation Cluster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","award":["N279-000-030-001"],"award-info":[{"award-number":["N279-000-030-001"]}],"id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biomaterials.2022.121843","type":"journal-article","created":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T02:38:53Z","timestamp":1664851133000},"page":"121843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["In-situ vaccination using dual responsive organelle targeted nanoreactors"],"prefix":"10.1016","volume":"290","author":[{"given":"Vishnu","family":"Sunil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbu","family":"Mozhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-5042","authenticated-orcid":false,"given":"Wenbo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Heng","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-725X","authenticated-orcid":false,"given":"Pramila Baban","family":"Ghode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish V.","family":"Thakor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1040-2121","authenticated-orcid":false,"given":"Chi-Hwa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2022.121843_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120974","article-title":"Convection enhanced delivery of light responsive antigen capturing oxygen generators for chemo-phototherapy triggered adaptive immunity","author":"Sunil","year":"2021","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121843_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nnano.2011.112","article-title":"Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment","volume":"6","author":"Mikhaylov","year":"2011","journal-title":"Nat. Nanotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121843_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1039\/C7CS00550D","article-title":"Dendrimers in combination with natural products and analogues as anti-cancer agents","volume":"47","author":"Mignani","year":"2018","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2022.121843_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2018.07.002","article-title":"Drug delivery systems for programmed and on-demand release","volume":"132","author":"Davoodi","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121843_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Trans. Med."},{"key":"10.1016\/j.biomaterials.2022.121843_bib6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3389\/fphar.2019.01369","article-title":"Recalcitrant issues and new frontiers in nano-pharmacology","volume":"10","author":"Bhardwaj","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biomaterials.2022.121843_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jconrel.2020.05.005","article-title":"Enhanced penetration of pro-apoptotic and anti-angiogenic micellar nanoprobe in 3D multicellular spheroids for chemophototherapy","volume":"323","author":"Mozhi","year":"2020","journal-title":"J. Contr. Release"},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121843_bib8","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1021\/acs.nanolett.7b03531","article-title":"Polymer prodrug-based nanoreactors activated by tumor acidity for orchestrated oxidation\/chemotherapy","volume":"17","author":"Li","year":"2017","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121843_bib9","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1021\/ja5105848","article-title":"Cell-penetrating hyperbranched polyprodrug amphiphiles for synergistic reductive milieu-triggered drug release and enhanced magnetic resonance signals","volume":"137","author":"Hu","year":"2015","journal-title":"J. Am. Chem. Soc."},{"issue":"25","key":"10.1016\/j.biomaterials.2022.121843_bib10","doi-asserted-by":"crossref","first-page":"21149","DOI":"10.1021\/acsami.8b05170","article-title":"Prodrug-based cascade self-assembly strategy for precisely controlled combination drug therapy","volume":"10","author":"Ha","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121843_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706220","article-title":"Dual drug backboned shattering polymeric theranostic nanomedicine for synergistic eradication of patient\u2010derived lung cancer","volume":"30","author":"Cong","year":"2018","journal-title":"Adv. Mater."},{"issue":"44","key":"10.1016\/j.biomaterials.2022.121843_bib12","doi-asserted-by":"crossref","first-page":"14980","DOI":"10.1021\/jacs.8b09396","article-title":"Tumor microenvironment-responsive ultrasmall nanodrug generators with enhanced tumor delivery and penetration","volume":"140","author":"Zhang","year":"2018","journal-title":"J. Am. Chem. Soc."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121843_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrd.2018.46","article-title":"The expanding role of prodrugs in contemporary drug design and development","volume":"17","author":"Rautio","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121843_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8939","article-title":"A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models","volume":"6","author":"Bhattacharyya","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121843_bib15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.biomaterials.2013.10.011","article-title":"Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds","volume":"35","author":"Sun","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121843_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2018.10.010","article-title":"ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy","volume":"188","author":"Pei","year":"2019","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121843_bib17","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/acs.nanolett.8b00737","article-title":"Disulfide bond-driven oxidation-and reduction-responsive prodrug nanoassemblies for cancer therapy","volume":"18","author":"Sun","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2022.121843_bib18","article-title":"Endogenous stimuli\u2010activatable nanomedicine for immune theranostics for cancer","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"18","key":"10.1016\/j.biomaterials.2022.121843_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201700244","article-title":"Gold and hairpin DNA functionalization of upconversion nanocrystals for imaging and in vivo drug delivery","volume":"29","author":"Han","year":"2017","journal-title":"Adv. Mater."},{"issue":"32","key":"10.1016\/j.biomaterials.2022.121843_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201700996","article-title":"Emerging nanotechnology and advanced materials for cancer radiation therapy","volume":"29","author":"Song","year":"2017","journal-title":"Adv. Mater."},{"issue":"47","key":"10.1016\/j.biomaterials.2022.121843_bib21","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1002\/adma.201503280","article-title":"Recent advances in upconversion nanoparticles\u2010based multifunctional nanocomposites for combined cancer therapy","volume":"27","author":"Tian","year":"2015","journal-title":"Adv. Mater."},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121843_bib22","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1021\/acsnano.6b02326","article-title":"Smart superstructures with ultrahigh pH-sensitivity for targeting acidic tumor microenvironment: instantaneous size switching and improved tumor penetration","volume":"10","author":"Li","year":"2016","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121843_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201603702","article-title":"An amphiphilic ruthenium polymetallodrug for combined photodynamic therapy and photochemotherapy in vivo","volume":"29","author":"Sun","year":"2017","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.biomaterials.2022.121843_bib24","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1073\/pnas.1522080113","article-title":"Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy","volume":"113","author":"Li","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"49","key":"10.1016\/j.biomaterials.2022.121843_bib25","doi-asserted-by":"crossref","first-page":"13662","DOI":"10.1002\/ange.201407234","article-title":"Reactive oxygen species\u2010responsive protein modification and its intracellular delivery for targeted cancer therapy","volume":"126","author":"Wang","year":"2014","journal-title":"Angew. Chem."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121843_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201600106","article-title":"Chemophototherapy: an emerging treatment option for solid tumors","volume":"4","author":"Luo","year":"2017","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121843_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms4546","article-title":"Porphyrin\u2013phospholipid liposomes permeabilized by near-infrared light","volume":"5","author":"Carter","year":"2014","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121843_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-018-06574-7","article-title":"A discrete organoplatinum (II) metallacage as a multimodality theranostic platform for cancer photochemotherapy","volume":"9","author":"Yu","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121843_bib29","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121843_bib30","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1600-0609.1993.tb00165.x","article-title":"Severe immunodeficiency in patients treated with fludarabine monophosphate","volume":"50","author":"Wijermans","year":"1993","journal-title":"Eur. J. Haematol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121843_bib31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0897190014546108","article-title":"Antineoplastic agents and the associated myelosuppressive effects: a review","volume":"27","author":"Barreto","year":"2014","journal-title":"J. Pharm. Pract."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121843_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bbamem.2007.11.008","article-title":"Studies on anticancer activities of antimicrobial peptides","volume":"1778","author":"Hoskin","year":"2008","journal-title":"Biochim. Biophys. Acta, Biomembr."},{"issue":"21","key":"10.1016\/j.biomaterials.2022.121843_bib33","first-page":"7709","article-title":"A proapoptotic peptide for the treatment of solid tumors","volume":"61","author":"Mai","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121843_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2018.11.004","article-title":"Peptide-based targeted therapeutics: focus on cancer treatment","volume":"292","author":"Araste","year":"2018","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121843_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0891-5849(00)00158-1","article-title":"How important is oxidative damage? Lessons from Alzheimer's disease","volume":"28","author":"Perry","year":"2000","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121843_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updates"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121843_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121843_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrclinonc.2014.111","article-title":"Therapeutic vaccines for cancer: an overview of clinical trials","volume":"11","author":"Melero","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121843_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrclinonc.2010.223","article-title":"Immune parameters affecting the efficacy of chemotherapeutic regimens","volume":"8","author":"Zitvogel","year":"2011","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121843_bib40","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1172\/JCI80009","article-title":"Therapeutic cancer vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121843_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6382","key":"10.1016\/j.biomaterials.2022.121843_bib42","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.aar7112","article-title":"Personalized vaccines for cancer immunotherapy","volume":"359","author":"Sahin","year":"2018","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121843_bib43","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41563-018-0147-9","article-title":"Biomaterial-assisted targeted modulation of immune cells in cancer treatment","volume":"17","author":"Wang","year":"2018","journal-title":"Nat. Mater."},{"issue":"5930","key":"10.1016\/j.biomaterials.2022.121843_bib44","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2022.121843_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.08.025","article-title":"Bioengineered immunomodulatory organelle targeted nanozymes for photodynamic immunometabolic therapy","volume":"350","author":"Sunil","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2022.121843_bib46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fphar.2020.00558","article-title":"Enhanced anti-glioma efficacy by borneol combined with CGKRK-modified paclitaxel self-assembled redox-sensitive nanoparticles","volume":"11","author":"Lv","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121843_bib47","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/mt.2013.191","article-title":"Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32","volume":"21","author":"Agemy","year":"2013","journal-title":"Mol. Ther."},{"issue":"42","key":"10.1016\/j.biomaterials.2022.121843_bib48","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.1114518108","article-title":"Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma","volume":"108","author":"Agemy","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121843_bib49","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1535-6108(03)00273-3","article-title":"Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma","volume":"4","author":"Hoffman","year":"2003","journal-title":"Cancer Cell"},{"issue":"30","key":"10.1016\/j.biomaterials.2022.121843_bib50","doi-asserted-by":"crossref","first-page":"8647","DOI":"10.1039\/c1cc12495a","article-title":"Self-assembling nanomicelles of a novel camptothecin prodrug engineered with a redox-responsive release mechanism","volume":"47","author":"Li","year":"2011","journal-title":"Chem. Commun."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121843_bib51","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/mp800049w","article-title":"Pharmacokinetics and biodistribution of nanoparticles","volume":"5","author":"Li","year":"2008","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121843_bib52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3892\/ol.2014.2634","article-title":"Tumor size predicts prognosis of head and neck synovial cell sarcoma","volume":"9","author":"Wushou","year":"2015","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121843_bib53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molcel.2016.06.010","article-title":"An autoinhibited dimeric form of BAX regulates the BAX activation pathway","volume":"63","author":"Garner","year":"2016","journal-title":"Mol. Cell"},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121843_bib54","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1158\/1078-0432.CCR-12-3314","article-title":"Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages","volume":"19","author":"Bloch","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121843_bib55","doi-asserted-by":"crossref","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2022.121843_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2013.00177","article-title":"Unique versus redundant functions of IL-1\u03b1 and IL-1\u03b2 in the tumor microenvironment","volume":"4","author":"Voronov","year":"2013","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.biomaterials.2022.121843_bib57","doi-asserted-by":"crossref","first-page":"7119","DOI":"10.1073\/pnas.0902745106","article-title":"IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation","volume":"106","author":"Ben-Sasson","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:15:14Z","timestamp":1758906914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222004835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":57,"alternative-id":["S0142961222004835"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121843","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-situ vaccination using dual responsive organelle targeted nanoreactors","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121843"}}